METROPOLIS - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.7
| Stock Code | METROPOLIS | Market Cap | 9,728 Cr. | Current Price | 1,876 ₹ | High / Low | 2,263 ₹ |
| Stock P/E | 67.5 | Book Value | 256 ₹ | Dividend Yield | 0.05 % | ROCE | 13.4 % |
| ROE | 10.5 % | Face Value | 2.00 ₹ | DMA 50 | 1,886 ₹ | DMA 200 | 1,912 ₹ |
| Chg in FII Hold | -0.84 % | Chg in DII Hold | 1.63 % | PAT Qtr | 38.0 Cr. | PAT Prev Qtr | 46.6 Cr. |
| RSI | 50.4 | MACD | -19.7 | Volume | 85,273 | Avg Vol 1Wk | 79,508 |
| Low price | 1,315 ₹ | High price | 2,263 ₹ | PEG Ratio | -4.83 | Debt to equity | 0.11 |
| 52w Index | 59.2 % | Qtr Profit Var | 38.9 % | EPS | 26.6 ₹ | Industry PE | 32.6 |
📊 Chart & Trend: Metropolis trades at ₹1,876, slightly below its 50 DMA (₹1,886) and 200 DMA (₹1,912). This indicates short-term and medium-term weakness, with the stock struggling to hold above key averages.
📉 Momentum Indicators: RSI at 50.4 shows neutral momentum. MACD at -19.7 confirms bearish divergence. Bollinger Bands suggest price is mid-range, with support near ₹1,850–₹1,870 and resistance around ₹1,900–₹1,920.
📈 Volume Trends: Current volume (85k) is slightly higher than the 1-week average (79k), reflecting modest participation but no strong buying conviction.
🔑 Entry Zone: ₹1,850–₹1,870 (near support and oversold levels).
🚪 Exit Zone: ₹1,900–₹1,920 (near resistance and 200 DMA).
📌 Trend Status: The stock is in consolidation with bearish bias, awaiting a breakout above ₹1,920 or breakdown below ₹1,850.
Positive
- EPS at ₹26.6 indicates steady earnings power.
- ROCE (13.4%) and ROE (10.5%) show moderate efficiency.
- DII holdings increased (+1.63%), showing strong domestic institutional support.
- Debt-to-equity ratio at 0.11 reflects low leverage.
Limitation
- Stock P/E at 67.5 is much higher than industry PE of 32.6.
- PEG ratio at -4.83 suggests valuation concerns relative to growth.
- Dividend yield at 0.05% is negligible.
- 52-week index at 59.2% shows moderate underperformance.
Company Negative News
- FII holdings decreased (-0.84%), showing reduced foreign investor confidence.
- Sequential PAT declined (₹46.6 Cr → ₹38.0 Cr).
Company Positive News
- DII stake increased significantly, supporting long-term confidence.
- Efficiency ratios remain stable despite PAT decline.
Industry
- Diagnostics sector PE at 32.6, much lower than Metropolis’ valuation of 67.5.
- Sector rotation favors healthcare diagnostics, but valuations remain stretched for premium players.
Conclusion
⚖️ Metropolis is consolidating with bearish short-term signals, trading below key averages. Entry near ₹1,850–₹1,870 offers margin of safety, while exits around ₹1,900–₹1,920 provide profit-taking opportunities. Despite weak technicals and reduced FII support, strong domestic institutional confidence and stable efficiency ratios provide resilience, though high valuations limit upside potential.
Would you like me to extend this into a peer benchmarking overlay with Dr. Lal PathLabs, Thyrocare, and Vijaya Diagnostic to highlight Metropolis’ relative valuation and technical strength within the diagnostics sector?